Khodadad Mehraein, MD
Pathologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis Testicular Mesothelioma
Cancer Antigen 125, CA Fibulin-3 Human MPF ELISA Kit Mesomark Osteopontin SOMAmer Panel
Dr. Mehraein graduated the medical school from the Tehran University of Medical Sciences School of Medicine and completed both his internship and residency program at the Maimonides Medical Center. He is specialized in Pathology and board certified in Anatomic Pathology and Clinical Pathology. Dr. Mehraein has been in practice for more than 20 years and during his career, he has also contributed to 3 publications of medical interest.
Tehran University of Medical Sciences School of Medicine
Medical School
Maimonides Medical Center
Internship
Maimonides Medical Center
Residency
American Board of Pathology - Anatomic Pathology & Clinical Pathology
Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy.
Bagley, R. G., Rouleau, C., Weber, W., Mehraein, K., Smale, R., Curiel, M., Callahan, M., Roy, A., Boutin, P., St Martin, T., Nacht, M., Teicher, B. A.; Microvasc Res. 2011 Nov.
See more >>Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
Rouleau, C., Curiel, M., Weber, W., Smale, R., Kurtzberg, L., Mascarello, J., Berger, C., Wallar, G., Bagley, R., Honma, N., Hasegawa, K., Ishida, I., Kataoka, S., Thu...; Clin Cancer Res. 2008 Nov 15.
See more >>Protective effect of glycine in mesenteric ischemia and reperfusion injury in a rat model.
Kallakuri, S., Ascher, E., Pagala, M., Gade, P., Hingorani, A., Scheinman, M., Mehraein, K., Jacob, T.; J Vasc Surg. 2003 Nov.
See more >>